Who owns Salix Pharmaceuticals?

Key details on Salix Pharmaceuticals (Ticker: SLXP)

Who owns Salix Pharmaceuticals?

Is SLXP a good stock to own? Find out who bought Salix Pharmaceuticals, who sold Salix Pharmaceuticals (SLXP) stock, and who holds a large position in Salix Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Schroder Investment Management 50.84M $3.40B Sept. 30, 2013
EQUITEC SPECIALISTS 9.66M $9.66M Dec. 31, 2014
Paulson & Co 5.81M $667.34M Dec. 31, 2014
FMR 5.40M $844.42M Sept. 30, 2014
BNP PARIBAS ARBITRAGE, SNC 4.12M $614.21M Dec. 31, 2013
Vanguard 3.78M $435.01M Dec. 31, 2014
Visium Asset Management 3.11M $356.98M Dec. 31, 2014
Bank of America Corporation 2.86M $191.35M Sept. 30, 2013
BlackRock Fund Advisors 2.76M $317.00M Dec. 31, 2014
TIAA-CREF Investment Management 2.59M $405.30M Sept. 30, 2014
Discovery Capital Management 2.19M $88.58M Dec. 31, 2012
STATE STREET CORPORATION 2.19M $251.40M Dec. 31, 2014
HealthCor Management 2.00M $79.66M June 30, 2011
Damian Sousa 1.87M $125.27M Sept. 30, 2013
JANA PARTNERS 1.86M $213.66M Dec. 31, 2014
HealthCor Management 1.82M $99.35M June 30, 2012
BlackRock Institutional Trust Company, N.A. 1.77M $202.92M Dec. 31, 2014
Ameriprise Financial 1.75M $215.28M June 30, 2014
VIKING GLOBAL INVESTORS 1.74M $199.78M Dec. 31, 2014
Inves 1.64M $188.36M Dec. 31, 2014
Janus Capital Management 1.61M $185.13M Dec. 31, 2014
MORGAN STANLEY 1.57M $180.22M Dec. 31, 2014
S.A.C. Capital Advisors 1.54M $62.26M Dec. 31, 2012
Franklin Resources 1.51M $100.08M June 30, 2013
OppenheimerFunds 1.51M $173.51M Dec. 31, 2014
Pentwater Capital Management 1.50M $172.98M Dec. 31, 2014
Wellington Management Company 1.48M $170.00M Dec. 31, 2014
Federated Investors 1.43M $148.08M March 31, 2014
Oak Ridge Investments 1.38M $92.35M Sept. 30, 2013
TimesSquare Capital Management 1.36M $168.20M June 30, 2014
SUSQUEHANNA INTERNATIONAL 1.30M $203.23M Sept. 30, 2014
GOLDMAN SACHS 1.29M $147.93M Dec. 31, 2014
Herndon Capital Management 1.28M $84.97M June 30, 2013

Who sold Salix Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Next Century Growth Investors Sept. 30, 2011 1.61M $47.52M
Nicholas Investments Partners June 30, 2011 5.25M $4.46M
Partner Fund Management March 31, 2011 1.51M $52.72M